ceftobiprole medocaril sodium
FDA approves Basilea’s intravenous antibiotic Zevtera for three indications
The regulator’s decision provides an additional treatment option for a number of serious bacterial infections
Basilea’s novel antibiotic reaches UK market
Zevtera can be used against a range of infections including MRSA
FDA approves antibacterial skin drug Orbactiv
US regulator authorises Medicines Company's treatment for ABSSSI
Cell wall inhibitors for bacterial infections
There are limited pipeline prospects to address this significant health issue